Bolt Biotherapeutics, Inc.
BOLTNASDAQHealthcare● Active
$4.72
+$0.16(+3.51%)
Market Cap$9069796
P/E Ratio—
52W High$7.35
52W Low$3.91
Bolt Biotherapeutics, Inc.（BOLT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BOLT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.70M | $7.69M | $7.88M | $5.73M | $1.26M |
| Cost of Revenue | $1.49M | $0.00M | $61.54M | $73.12M | $75.66M |
| Gross Profit | $6.20M | $7.69M | ($53.67M) | ($67.39M) | ($74.39M) |
| Gross Margin %(computed) | 80.62% | 100.00% | -681.39% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $28.53M | $57.47M | $61.54M | $73.12M | $75.66M |
| G&A Expenses | $13.79M | $18.46M | $22.53M | $22.93M | $18.39M |
| Total Operating Expenses | $40.84M | $80.74M | $22.53M | $22.93M | $18.39M |
| Operating Income | ($34.63M) | ($73.05M) | ($76.20M) | ($90.32M) | ($92.79M) |
| Operating Margin %(computed) | -450.07% | -949.91% | -967.45% | — | — |
| Interest Income | $2.50M | $5.25M | $7.00M | $2.22M | $0.28M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($33.38M) | ($63.12M) | ($69.20M) | ($88.10M) | ($98.59M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($33.38M) | ($63.12M) | ($69.20M) | ($88.10M) | ($98.59M) |
| Net Margin %(computed) | -433.74% | -820.78% | -878.58% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-17.85 | $-1.65 | $-1.83 | $-2.30 | $-2.79 |
| Wtd Avg Shares | 1.87M | 38.18M | 37.81M | 37.36M | 37.40M |
| EBITDA | ($33.14M) | ($66.45M) | ($74.34M) | ($88.66M) | ($91.59M) |
| EBITDA Margin %(computed) | -430.70% | -864.17% | -943.91% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Bolt Biotherapeutics, Inc.
关于Bolt Biotherapeutics, Inc.（BOLT）损益表
Bolt Biotherapeutics, Inc.（BOLT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BOLT实现营收$0.01B，毛利润$0.01B（毛利率80.62%），净利润($0.03B)（净利率-433.74%）。
常见问题
BOLT · 4 问Bolt Biotherapeutics, Inc.（BOLT）2025财年营收为$0.01B，同比up0.1%。
BOLT revenueBOLT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08